Mixed vaginitis. What's new? Features of the course and therapy of mixed vaginitis

Dobrokhotova Yu.E.; Markova E.A.

doi:https://doi.org/10.17116/repro202228041137

Close metadata

THE OBJECTIVE OF THE STUDY

Study and analysis of literature sources on the prevalence, etiology and methods of treatment of mixed vaginitis.

MATERIAL AND METHODS

A literature review of data for the last 10 years on the prevalence of mixed vaginitis, etiological factors and treatment problems has been performed.

RESULTS

Up-to-date data on the high prevalence of mixed vaginitis, the features of the course of mixed infection, the formation of resistance to treatment were obtained. It is concluded that there is a need to revise approaches to the diagnosis and treatment of mixed vaginitis.

CONCLUSION

Currently, in the treatment of patients with mixed vaginitis, preference is given to local combined broad-spectrum drugs for the effective elimination of pathogens, prevention of the formation of redicivs and the creation of conditions for the restoration of their own microflora. The medicine Polygynax, which includes 3 components against the most common pathogens of vaginitis, can be considered a rational choice: two antibiotics: neomycin and polymyxin B and antimycotic - nystatin.

Keywords:

mixed vaginitis

polymyxin B

neomycin

nystatin

aerobic vaginitis

vaginal infections

antibiotic resistance

Authors:

Dobrokhotova Yu.E.

Pirogov Russian National Research Medical University

SPIN RSCI: 2925-9948
Scopus AuthorID: 57188592250
ORCID: 0000-0002-7830-2290

Markova E.A.

Pirogov Russian National Research Medical University

Scopus AuthorID: 56181386000
ORCID: 0000-0002-9491-9303

Received:

15.08.2022

Accepted:

18.08.2022

Close metadata

References:

Pacha-Herrera D, Vasco G, Cruz-Betancourt C, Galarza JM, Barragán V, Machado A. Vaginal Microbiota Evaluation and Lactobacilli Quantification by qPCR in Pregnant and Non-Pregnant Women: A Pilot Study. Frontiers in Cellular and Infection Microbiology. 2020;10:303. https://doi.org/10.3389/fcimb.2020.00303
Jahic M, Mulavdic M, Nurkic J, Jahic E, Nurkic M. Clinical Characteristics of Aerobic Vaginitis and its Association to Vaginal Candidiasis, Trichomonas Vaginitis and Bacterial Vaginosis. Medical Archives. 2013;67(6):428-430. https://doi.org/10.5455/medarh.2013.67.428-430
Fan A, Yue Y, Geng N, Zhang H, Wang Y, Xue F. Aerobic Vaginitis and Mixed Infections: Comparison of Clinical and Laboratory Findings. Archives of gynecology and obstetrics. 2013;287(2):329-335. https://doi.org/10.1007/s00404-012-2571-4
Wang H, Huang Z, Wu Z, Qi X, Lin D. An Epidemiological Study on Vaginitis in 6,150 Women of Reproductive Age in Shanghai. The New Microbiologica. 2017;40(2):113-118.
Rivers CA, Adaramola OO, Schwebke JR. Prevalence of Bacterial Vaginosis and Vulvovaginal Candidiasis Mixed Infection in a Southeastern American STD Clinic. Sexually Transmitted Diseases. 2011;38(7):672-674. https://doi.org/10.1097/OLQ.0b013e31820fc3b8
Radzinsky VE, Ordiyants IM, Pobedinskaya OS, Buyanova NV. Current aspects of correction of dysbiotic disorders in gynecologic practice. Akusherstvo i ginekologiya. 2013;2:72-76. (In Russ.).
2018 European (IUSTI/WHO) Guideline on the Management of Vaginal Discharge. Accessed August 16, 2022. https://www.iusti.org/regions/europe/pdf/2018/IUSTIvaginalDischargeGuidelines2018.pdf
Kira EF. Bakterial’nyj vaginoz. Izd. 2-e, ispr., dop. M.: MIA; 2012.
Ginekologiya. Nacional’noe rukovodstvo. Pod red. Savel’evoj GM, Suhih GT, Serova VN, Radzinskogo VE, Manuhina IB. 2-e izd. M.: GEOTAR-Media; 2017.
Diagnostika i lechenie zabolevanij, soprovozhdayushchihsya patologicheskimi vydeleniyami iz polovyh putej zhenshchin. Klinicheskie rekomendacii. M., 2019. Accessed August 16, 2022. (In Russ.). https://www.medkirov.ru/docs/id/pdf
Amsel R, Totten PA, Spiegel CA, Chen KC, Eschenbach D, Holmes KK. Nonspecific vaginitis: diagnostic criteria and microbial and epidemiologic associations. The American Journal of Medicine. 1983;74(1):14-22. https://doi.org/10.1016/0002-9343(83)91112-9
Sherrard J, Donders G, White D, Jensen JS; European IUSTI. European (IUSTI/WHO) Guideline on the Management of Vaginal Discharge. International Journal of STD & AIDS. 2011;22(8):421-429. https://doi.org/10.1258/ijsa.2011.011012
Liang Q, Li N, Song S, Zhang A, Li N, Duan Y. High-Dose Nifuratel for Simple and Mixed Aerobic Vaginitis: A Single-Center Prospective Open-Label Cohort Study. The Journal of Obstetrics and Gynaecology Research. 2016;42(10):1354-1360. https://doi.org/10.1111/jog.13052
Hainer BL, Gibson MV. Vaginitis. American Family Physician. 2011;83(7):807-815.
Qi W, Li H, Wang C, Li H, Zhang B, Dong M, Fan A, Han C, Xue F. Recent Advances in Presentation, Diagnosis and Treatment for Mixed Vaginitis. Frontiers in Cellular and Infection Microbiology. 2021:11:759795. https://doi.org/10.3389/fcimb.2021.759795
Wang ZL, Fu LY, Xiong ZA, Qin Q, Yu TH, Wu YT, Hua YY, Zhang YH. Diagnosis and Microecological Characteristics of Aerobic Vaginitis in Outpatients Based on Preformed Enzymes. Taiwanese Journal of Obstetrics and Gynecology. 2016;55(1):40-44. https://doi.org/10.1016/j.tjog.2015.06.012
Vospalitel’nye bolezni shejki matki, vlagalishcha i vul’vy. Klinicheskie rekomendacii. OOO «Rossijskoe obshchestvo akusherov-ginekologov (ROAG)». 2021. Accessed August 16, 2022. (In Russ.). https://chelsma.ru/files/misc/vospalitelnyeboleznishejkimatki.pdf
Dovletkhanova ER, Abakarova PR. The possibility of using complex drugs in the treatment of polymicrobial vulvovaginitis. Akusherstvo i ginekologiya. 2012;4:8-11. (In Russ.).
Beaussart A, Herman P, El-Kirat-Chatel S, Lipke PN, Kucharíková S, Van Dijck P, Dufrêne YF. Single-Cell Force Spectroscopy of the Medically Important Staphylococcus Epidermidis-Candida Albicans Interaction. Nanoscale. 2013;5(22):10894-10900. https://doi.org/10.1039/c3nr03272h
Roux D, Gaudry S, Dreyfuss D, El-Benna J, de Prost N, Denamur E, Saumon G, Ricard JD. Candida Albicans Impairs Macrophage Function and Facilitates Pseudomonas Aeruginosa Pneumonia in Rat. Critical Care Medicine. 2009;37(3):1062-1067. https://doi.org/10.1097/CCM.0b013e31819629d2
Srinivasan S, Liu C, Mitchell CM, Fiedler TL, Thomas KK, Agnew KJ, Marrazzo JM, Fredricks DN. Temporal Variability of Human Vaginal Bacteria and Relationship with Bacterial Vaginosis. PLoS One. 2010;5(4): e10197. https://doi.org/0.1371/journal.pone.0010197
Serretiello E, Santella B, Folliero V, Iervolino D, Santoro E, Manente R, Dell’Annunziata F, Sperlongano R, Crudele V, De Filippis A, Galdiero M, Franci G, Boccia G. Prevalence and Antibiotic Resistance Profile of Bacterial Pathogens in Aerobic Vaginitis: A Retrospective Study in Italy. Antibiotics. 2021;10(9):1133. https://doi.org/10.3390/antibiotics10091133
Yu XY, Fu F, Kong WN, Xuan QK, Wen DH, Chen XQ, He YM, He LH, Guo J, Zhou AP, Xi YH, Ni LJ, Yao YF, Wu WJ. Streptococcus Agalactiae Inhibits Candida Albicans Hyphal Development and Diminishes Host Vaginal Mucosal TH17 Response. Frontiers in microbiology. 2018;9:198. https://doi.org/10.3389/fmicb.2018.00198
Malova OI, Afanasyeva IG, Gusevskaya KA. Acute vaginitis of mixed etiology and a modern approach to treatment. Akusherstvo i ginekologiya. Novosti. Mneniya. Obuchenie. 2019;7(4-26):79-86. (In Russ.). https://doi.org/10.24411/2303-9698-2019-14007
Kuznetsova IV, Shikh EV. Aerobic vaginitis: terminological news and the choice of empirical therapy. StatusPraesens. 2016;4(33):57-63. (In Russ.).
De Vos W, Engstrand L, Drago L, Reid G, Schauber J, Hay R, Mendling W, Schaller M, Spiller R, Gahan CG, Rowland I. Human Microbiota in Health and Disease. SelfCare; 2012(3):1-68.
Curry A, Williams T, Penny ML. Pelvic Inflammatory Disease: Diagnosis, Management, and Prevention. American Family Physician. 2019;100(6):357-364.
Dong M, Wang C, Li H, Yan Y, Ma X, Li H, Li X, Wang H, Zhang Y, Qi W, Meng K, Tian W, Wang Y, Fan A, Han C, Donders GGG, Xue F. Aerobic Vaginitis Diagnosis Criteria Combining Gram Stain with Clinical Features: An Establishment and Prospective Validation Study. Diagnostics. 2022;12(1):185. https://doi.org/10.3390/diagnostics12010185
Kumar B, Gupta S. Sexually Transmitted Infections. 2nd ed. Elsevier Health Sciences; 2014.
Baron EJ, Miller JM, Weinstein MP, Richter SS, Gilligan PH, Thomson RB Jr, Bourbeau P, Carroll KC, Kehl SC, Dunne WM, Robinson-Dunn B, Schwartzman JD, Chapin KC, Snyder JW, Forbes BA, Patel R, Rosenblatt JE, Pritt BS. Executive summary: a guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM). Clinical Infectious Diseases. 2013;57(4):485-488. https://doi.org/10.1093/cid/cit441
Lohse MB, Gulati M, Johnson AD, Nobile CJ. Development and Regulation of Single- and Multi-Species Candida Albicans Biofilms. Nature Reviews. Microbiology. 2018;16(1):19-31. https://doi.org/10.1038/nrmicro.2017.107
Sobel JD, Subramanian C, Foxman B, Fairfax M, Gygax SE. Mixed vaginitis more than coinfection and with therapeutic implications. Current Infectious Disease Reports. 2013;15(2):104-108.
Tumietto F, Posteraro B, Sanguinetti M. Looking for Appropriateness in the Cure of Mixed Vaginitis: The Role of Fenticonazole as an Empiric Treatment. Future Microbiology. 2019;14:1349-1355. https://doi.org/10.2217/fmb-2019-018
Novakov Mikić A, Stojic S. Study results on the use of different therapies for the treatment of vaginitis in hospitalised pregnant women. Archives of Gynecology and Obstetrics. 2015;292(2):371-376. https://doi.org/10.1007/s00404-015-3638-9
Rogovskaya SI, Gomberg MA. Time of changes. Dynamic changes in the vaginal microecosystem and treatment of vaginal infection. StatusPraesens. 2019;4(59):111-117. (In Russ.).
Rasporyazhenie Pravitel’stva Rossijskoj Federacii ot 25.09.2017 g. № 2045-r «Ob utverzhdenii Strategii preduprezhdeniya rasprostraneniya antimikrobnoj rezistentnosti v Rossijskoj Federacii na period do 2030 goda i plana meropriyatij po ee realizacii s proektom doklada Prezidentu Rossijskoj Federacii po dannomu voprosu». Ssylka aktivna na 16.08.22. Accessed August 16, 2022. (In Russ.). https://publication.pravo.gov.ru/Document/View/0001201710030067?index=1&rangeSize=1
Lassey AT, Adanu KR, Newman MJ, Opintah JA. Potential pathogens in the lower genital tract at manual vacuum aspiration for incomplete abortion in Korle Bu Teaching Hospital, Ghana. East African Medical Journal. 2004;81(8):398-401. https://doi.org/10.4314/eamj.v81i8.9200
Radzinskiĭ VE, Ordiiants IM, Pobedinskaia OS, Zykov EV. Experience with Polygynax used in the treatment of vulvovaginitis caused by the aerobic and mixed microflora. Rossijskij vestnik akushera-ginekologa. 2016;16(1):84-88. (In Russ.). https://doi.org/10.17116/rosakush201616184-88
Javed A, Parvaiz F, Manzoor S. Bacterial vaginosis: An insight into the prevalence, alternative treatments regimen and it’s associated resistance patterns. Microbial pathogenesis. 2019;127:21-30. https://doi.org/10.1016/j.micpath.2018.11.046
Romanik MK, Ekiel AM, Tomana L, Martirosian G. The bacterial vaginosis-treatment problems. Wiadomosci lekarskie. 2007;60(1-2):64-67.
Alauzet C, Lozniewski A, Marchandin H. Metronidazole resistance and nim genes in anaerobes: A review. Anaerobe. 2019;55:40-53. https://doi.org/10.1016/j.anaerobe.2018.10.004
Verwijs MC, Agaba SK, Darby AC, van de Wijgert JHHM. Impact of oral metronidazole treatment on the vaginal microbiota and correlates of treatment failure. American Journal of Obstetrics and Gynecology. 2020;222(2):157.e1-157.e13. https://doi.org/10.1016/j.ajog.2019.08.008
Lee CY, Cheu RK, Lemke MM, Gustin AT, France MT, Hampel B, Thurman AR, Doncel GF, Ravel J, Klatt NR, Arnold KB. Quantitative modeling predicts mechanistic links between pre-treatment microbiome composition and metronidazole efficacy in bacterial vaginosis. Nature Communications. 2020;11(1):6147. https://doi.org/10.1038/s41467-020-19880-w
Cools P, Jespers V, Hardy L, Crucitti T, Delany-Moretlwe S, Mwaura M, Ndayisaba GF, van de Wijgert JH, Vaneechoutte M. A Multi-Country Cross-Sectional Study of Vaginal Carriage of Qi et al. Recent Advances for Mixed Vaginitis Group B Streptococci (GBS) and Escherichia Coli in Resource-Poor Settings: Prevalences and Risk Factors. PloS One. 2016;11(1):e0148052. https://doi.org/10.1371/journal.pone.0148052
Schlecht LM, Peters BM, Krom BP, Freiberg JA, Hänsch GM, Filler SG, Jabra-Rizk MA, Shirtliff ME. Systemic Staphylococcus Aureus Infection Mediated by Candida Albicans Hyphal Invasion of Mucosal Tissue. Microbiology. 2015;161(Pt 1):168-181. https://doi.org/10.1099/mic.0.083485-0
Godovalov AP, Gushchin MO, Karpunina TI. Features of inter-microbial relations in the infertile women’s vagina microbiota. Medicinskij vestnik Kavkaza. 2019;14(1.1):40-44. (In Russ.). https://doi.org/10.14300/mnnc.2019.14045
Kira EF, Savicheva AM. Review of international and Russian scientific evidence on the use of Poliginax for the treatment and prevention of nonspecific (aerobic), candidiasis and mixed vaginitis. Zdorov’e zhenshchiny. 2018;3(129):58. (In Russ.).
Poirel L, Jayol A, Nordmann P. Polymyxins: Antibacterial Activity, Susceptibility Testing, and Resistance Mechanisms Encoded by Plasmids or Chromosomes. Clinical Microbiology Reviews. 2017;30(2):557-596. https://doi.org/10.1128/CMR.00064-16
Krause KM, Serio AW, Kane TR, Connolly LE. Aminoglycosides: An Overview. Cold Spring Harbor Perspectives in Medicine. 2016;6(6):a027029. https://doi.org/10.1101/cshperspect.a027029
Kira EF, Savicheva AM. Review of international and Russian scientific data on the use of Polygynax for the treatment and prevention of nonspecific (aerobic), candidiasis and mixed vaginitis. Rossijskij vestnik akushera-ginekologa. 2018;18(2):52-64. (In Russ.). https://doi.org/10.17116/rosakush201818252-64
Wang FJ, Zhang D, Liu ZH, Wu WX, Bai HH, Dong HY. Species distribution and in vitro antifungal susceptibility of vulvovaginal Candida isolates in China. Chinese Medical Journal. 2016;129(10):1161-1165. https://doi.org/10.4103/0366-6999.181964
Bohbot JM, Goubard A, Aubin F, Mas Y, Coatantiec E, Lucas N, Verrière F. PRISM study: Comparison of a nystatin-neomycin-polymyxin B combination with miconazole for the empirical treatment of infectious vaginitis. Medecine et Maladies Infectieuses. 2019;49(3):194-201. https://doi.org/10.1016/j.medmal.2019.01.011
Neut C, Verriere F, Nelis HJ, Coenye T. Topical Treatment of Infectious Vaginitis: Effects of Antibiotic, Antifungal and Antiseptic Drugs on the Growth of Normal Vaginal Lactobacillus Strains. Open Journal of Obstetrics and Gynecology. 2015;(5):173-180.
Boisnic C, Branchet MC, Bertaina I. Evaluation of the anti-inflammatory effect of the drug Polizhinax. Medical Aspects of Women’s Health. 2012;4(56):2-3.
Bohbot JM, Sednaoui P, Verriere F. Nystatin-Neomycin Polymyxin B Combination: Efficacy and tolerance as 1st-line local treatment of infectious vaginitis. Open Journal of Obstetrics and Gynecology. 2014;4(7):445-454. https://doi.org/10.4236/ojog.2014.47065
Serov VN, Shapovalenko SA. Rational therapy of vulvovaginitis of mixed etiology and prevention of relapses. Russkij medicinskij Zhurnal. 2003;11(16):946-949. (In Russ.).